Ajinomoto Co Inc
TSE:2802
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 636.5
4 438
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Ajinomoto Co Inc
Ajinomoto Co., Inc., a household name synonymous with umami, has woven a rich tapestry in the fabric of the global food industry. Originally starting its journey in 1908, the company was founded by Dr. Kikunae Ikeda, who isolated and identified the flavor-enhancing properties of monosodium glutamate (MSG). It began its commercial journey by marketing this unique seasoning under the brand name "Ajinomoto," which translates to "essence of taste" in Japanese. Building upon this foundation, Ajinomoto has expanded far beyond MSG, leveraging its biochemical prowess to create a diverse range of food products and ingredients. This transition from a single product line to a multitude of culinary offerings has established Ajinomoto as a global leader in the food industry, catering to numerous markets with products that enhance the flavors of everyday meals.
More than just a staple in pantries worldwide, Ajinomoto delves into the scientific realm of food and health. Its business model capitalizes not only on traditional seasoning products but also on innovative solutions in amino acids and wellness markets. The company generates revenue by harnessing biotechnologies to produce amino acids for pharmaceuticals, nutritional supplements, and the burgeoning wellness industry. Ajinomoto combines its biochemical expertise with a deep understanding of consumer trends to develop novel products that align with health and sustainability. Its strategic investments in technology and research empower the company to navigate contemporary challenges, ensuring its relevance and growth in an evolving marketplace. Through this dual focus on taste and health, Ajinomoto maintains its charismatic presence from bustling markets in Japan to homes across the globe.
Ajinomoto Co., Inc., a household name synonymous with umami, has woven a rich tapestry in the fabric of the global food industry. Originally starting its journey in 1908, the company was founded by Dr. Kikunae Ikeda, who isolated and identified the flavor-enhancing properties of monosodium glutamate (MSG). It began its commercial journey by marketing this unique seasoning under the brand name "Ajinomoto," which translates to "essence of taste" in Japanese. Building upon this foundation, Ajinomoto has expanded far beyond MSG, leveraging its biochemical prowess to create a diverse range of food products and ingredients. This transition from a single product line to a multitude of culinary offerings has established Ajinomoto as a global leader in the food industry, catering to numerous markets with products that enhance the flavors of everyday meals.
More than just a staple in pantries worldwide, Ajinomoto delves into the scientific realm of food and health. Its business model capitalizes not only on traditional seasoning products but also on innovative solutions in amino acids and wellness markets. The company generates revenue by harnessing biotechnologies to produce amino acids for pharmaceuticals, nutritional supplements, and the burgeoning wellness industry. Ajinomoto combines its biochemical expertise with a deep understanding of consumer trends to develop novel products that align with health and sustainability. Its strategic investments in technology and research empower the company to navigate contemporary challenges, ensuring its relevance and growth in an evolving marketplace. Through this dual focus on taste and health, Ajinomoto maintains its charismatic presence from bustling markets in Japan to homes across the globe.
Flat First-Half Results: Ajinomoto’s sales and business profit for the first half of FY2025 were nearly unchanged year-on-year, coming in at JPY 738.8 billion in sales and JPY 86.7 billion in business profit.
Guidance Maintained: Despite being behind schedule in some areas, management kept the full-year forecast unchanged and expects a significant profit increase in the second half, citing improved conditions and recovery measures.
Segment Performance: Seasonings and Foods and Frozen Foods saw profit declines, but Healthcare & Functional Materials performed strongly, with Functional Materials hitting 120% of prior-year levels.
Frozen Food Challenges: Domestic home-use frozen foods suffered from lost market share to private brands after price hikes, but recent strategy revisions are already showing positive results.
Shareholder Returns: Announced a new JPY 80 billion share buyback program, following the ongoing JPY 100 billion buyback, as part of efforts to enhance capital efficiency.
Competitive Pressure: Management acknowledged intensified competition from Chinese manufacturers in Umami seasonings and is taking both short- and long-term actions, including legal and operational measures.
Strategic Investments: Significant one-off expenses were incurred in the first half, particularly for the commercialization of Forge (gene therapy CDMO), but recurring SG&A investments will continue.
Outlook & Growth Drivers: Management expects recovery in lagging segments and continued strength in Healthcare and Functional Materials, underpinned by product innovation, structural reforms, and expanded licensing.
